Personal information

No personal information available

Activities

Collapse all

Employment (3)

University of Rochester Medical Center: Rochester, NY, US

2018-09 to 2021-06
Employment
Source: Self-asserted source
John R Lozada

Dana-Farber Cancer Institute: Boston, MA, US

2018-05 to 2019-08
Employment
Source: Self-asserted source
John R Lozada

Memorial Sloan Kettering Cancer Center: New York, New York, US

2016-06 to 2017-08
Employment
Source: Self-asserted source
John R Lozada

Education and qualifications (2)

University of Minnesota: Minneapolis, Minnesota, US

2021-06 to present | M.D./Ph.D.
Education
Source: Self-asserted source
John R Lozada

University of Rochester: Rochester, NY, US

2017-08 to 2020-12 | B.S. Molecular Genetics
Education
Source: Self-asserted source
John R Lozada

Works (10)

Histologic Classification and Molecular Signature of Polymorphous Adenocarcinoma (PAC) and Cribriform Adenocarcinoma of Salivary Gland (CASG): An International Interobserver Study.

The American journal of surgical pathology
2020-04-01 | Journal article
DOI: 10.1097/pas.0000000000001431
PMID: 31917707
Source: Self-asserted source
John R Lozada

Whole-Exome Analysis of Metaplastic Breast Carcinomas with Extensive Osseous Differentiation.

Histopathology
2020-02-11 | Journal article
DOI: 10.1111/his.14088
PMID: 32043609
Source: Self-asserted source
John R Lozada

Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2020-01-02 | Journal article
DOI: 10.1038/s41379-019-0442-2
PMID: 31896809
PMC: PMC7286791
Source: Self-asserted source
John R Lozada

Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2019-09-06 | Journal article
DOI: 10.1038/s41379-019-0351-4
PMID: 31492931
PMC: PMC6930326
Source: Self-asserted source
John R Lozada

Homologous recombination DNA repair defects in PALB2-associated breast cancers.

NPJ breast cancer
2019-08-08 | Journal article
DOI: 10.1038/s41523-019-0115-9
PMID: 31428676
PMC: PMC6687719
Source: Self-asserted source
John R Lozada

Massively parallel sequencing analysis of benign melanocytic naevi.

Histopathology
2019-05-24 | Journal article
DOI: 10.1111/his.13843
PMID: 30791119
PMC: PMC6752735
Source: Self-asserted source
John R Lozada

Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.

Nature communications
2018-08-30 | Journal article
DOI: 10.1038/s41467-018-05886-y
PMID: 30166553
PMC: PMC6117336
Source: Self-asserted source
John R Lozada

Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.

Histopathology
2018-06-01 | Journal article
DOI: 10.1111/his.13522
PMID: 29603332
PMC: PMC6783257
Source: Self-asserted source
John R Lozada

Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.

Nature communications
2018-05-08 | Journal article
DOI: 10.1038/s41467-018-04128-5
PMID: 29739933
PMC: PMC5940840
Source: Self-asserted source
John R Lozada

Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis-generating study

Histopathology
2017-07-05 | Journal article
DOI: 10.1111/his.13258
Contributors: John R Lozada; Kathleen A Burke; Aoife Maguire; Fresia Pareja; Raymond S Lim; Jisun Kim; Rodrigo Gularte-Merida; Melissa P Murray; Edi Brogi; Britta Weigelt et al.
Source: Self-asserted source
John R Lozada via Crossref Metadata Search
How many people are using ORCID?